The total protein and membrane expressions of PD-L1 were remarkably reduced upon IGF2BP3 disruption in breast cancer cells (Fig. 3b, c, Additional file 3: Fig. S3c, d). This evidence concerns the gene IGF2BP3 and breast carcinoma.